LOVO-CEL

LIVE

Serial Number

79316992

Owner

bluebird bio, Inc.

Attorney

Christopher K. Albert

Filing Date

Apr 22, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LOVO-CEL Trademark

Serial Number: 79316992 • Registration: 6829776

LOVO-CEL is a trademark filed by bluebird bio, Inc. on April 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Legal Representation

Attorney of Record

Christopher K. Albert

158 trademarks filed View all →

Correspondence Address

Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.

155 Seaport Blvd.

Boston, MA 02210

United States

Trademark Details

Filing Date

April 22, 2021

Registration Date

August 30, 2022

Published for Opposition

June 14, 2022

Goods & Services

Pharmaceutical preparations and substances for treatment of genetic diseases, namely, sickle cell disease

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 18, 2025 ADCH

NEW REPRESENTATIVE AT IB RECEIVED

Nov 14, 2025 NREP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 18, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 18, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 18, 2025 REAP

NEW REPRESENTATIVE AT IB RECEIVED

Sep 13, 2024 NREP

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 23, 2023 ADCH

FINAL DECISION TRANSACTION PROCESSED BY IB

Jan 4, 2023 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Dec 9, 2022 FICS

FINAL DISPOSITION PROCESSED

Dec 9, 2022 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 30, 2022 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 30, 2022 NRCC

REGISTERED-PRINCIPAL REGISTER

Aug 30, 2022 R.PR

CHANGE OF NAME/ADDRESS REC'D FROM IB

Aug 26, 2022 ADCH

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 14, 2022 NPUB

PUBLISHED FOR OPPOSITION

Jun 14, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 25, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 11, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 12, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 12, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 12, 2022 TROA

CHANGE OF OWNER RECEIVED FROM IB

Jan 20, 2022 CHLD

REFUSAL PROCESSED BY IB

Nov 5, 2021 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 13, 2021 RFCS

REFUSAL PROCESSED BY MPU

Oct 13, 2021 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 23, 2021 RFCR

NON-FINAL ACTION WRITTEN

Sep 22, 2021 CNRT

ASSIGNED TO EXAMINER

Sep 21, 2021 DOCK

APPLICATION FILING RECEIPT MAILED

Aug 10, 2021 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 6, 2021 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 5, 2021 REPR

Related Trademarks

More from this Owner

G GENETIX BIOTHERAPEUTICS

GENETIX BIOTHERAPEUTICS

G GENETIX BIOTHERAPEUTICS

ZYNTEGLO

More in Same Class

CELL FORGE

CPO